Evidence map›Paper›PMID 23714342›Full record

ReviewInfectious disease clinics of North America2013

Emerging fungal infections in solid organ transplant recipients.

Shmuel Shoham

Abstract readReview
In one paragraph

Review in Infectious disease clinics of North America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Journal of fungi (Basel, Switzerland) · 2023
    Review
  5. Article
  6. Review
  7. Fungal evolution: major ecological adaptations and evolutionary transitions.Biological reviews of the Cambridge Philosophical Society · 2019
    Review
  8. Article
  9. Article
  10. Phaeohyphomycosis in Transplant Patients.Journal of fungi (Basel, Switzerland) · 2015
    Review
  11. The neurology of solid organ transplantation.Current neurology and neuroscience reports · 2015
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Surgically Managed Deep Sternal Wound Infection After Heart Transplantation.Transplant infectious disease : an official journal of the Transplantation Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Shmuel ShohamTransplant and Oncology Infectious Diseases Program, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. sshoham1@jhmi.edu

Funding

Patient Oriented Research in Transplant and Oncology IDK24AI085118 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MARR, KIEREN A. · 2010 to 2014
$995k
NIAID NIH HHS K24 AI085118
6 · The paper itself

Abstract

The most important emerging and rare fungal pathogens in solid organ transplant recipients are the Zygomycetes, Scedosporium, Fusarium, and the dark molds. Factors affecting the emergence of these fungi include the combination of intensive immunosuppressive regimens with increasingly widespread use of long-term azole antifungal therapy; employment of aggressive diagnostic approaches (eg, sampling of bronchoalveolar lavage fluid); and changes in patients' interactions with the environment. This article reviews the epidemiology, microbiology, and clinical impact of emerging fungal infections in solid organ transplant recipients, and provides up-to-date recommendations on their treatment.

Indexed as

TransplantationTransplantsAntifungal AgentsDebridementFungiHumansImmunocompromised HostMycosesOpportunistic InfectionsAntifungal Agents

Identifiers

PMID23714342
PMCPMC3690580

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.